A novel anti‐c‐Kit antibody–drug conjugate to treat wild‐type and activating‐mutant c‐Kit‐positive tumors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel anti‐c‐Kit antibody–drug conjugate to treat wild‐type and activating‐mutant c‐Kit‐positive tumors
Authors
Keywords
-
Journal
Molecular Oncology
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-08-19
DOI
10.1002/1878-0261.13084
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical Activity of PI3K Inhibitor Copanlisib in Gastrointestinal Stromal Tumor
- (2020) Alfonso García-Valverde et al. MOLECULAR CANCER THERAPEUTICS
- Development and characterization of a fully human antibody targeting SCF/c-kit signaling
- (2020) Jin-Ock Kim et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Maytansine-bearing antibody-drug conjugates induce in vitro hallmarks of immunogenic cell death selectively in antigen-positive target cells
- (2019) Maxine Bauzon et al. OncoImmunology
- Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation
- (2019) Agnieszka Czechowicz et al. Nature Communications
- A juxtacrine/paracrine loop between C-Kit and stem cell factor promotes cancer stem cell survival in epithelial ovarian cancer
- (2019) Elena Laura Mazzoldi et al. Cell Death & Disease
- SCF (Stem Cell Factor) and cKIT Modulate Pathological Ocular Neovascularization
- (2019) Koung Li Kim et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Atializumab, a humanized anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) antibody significantly improves nephritis in (NZB/NZW) F1 mice
- (2019) Chin Hee Mun et al. BIOMATERIALS
- Cancer Stem Cells and Neuroblastoma: Characteristics and Therapeutic Targeting Options
- (2019) Veronica Veschi et al. Frontiers in Endocrinology
- Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of Cathepsin G and Neutrophil Elastase
- (2019) Caroline Schoenherr et al. PLoS One
- Mechanistic Insights of an Immunological Adverse Event Induced by an Anti-KIT Antibody Drug Conjugate and Mitigation Strategies
- (2018) Lawrence L'Italien et al. CLINICAL CANCER RESEARCH
- Preclinical Antitumor Activity of a Novel Anti–c-KIT Antibody–Drug Conjugate against Mutant and Wild-type c-KIT–Positive Solid Tumors
- (2018) Tinya Abrams et al. CLINICAL CANCER RESEARCH
- Challenges and new frontiers in analytical characterization of antibody-drug conjugates
- (2018) Anil Wagh et al. mAbs
- Oncogenic signaling by Kit tyrosine kinase occurs selectively on the Golgi apparatus in gastrointestinal stromal tumors
- (2017) Y Obata et al. ONCOGENE
- Overexpression of the cancer stem cell marker CD117 predicts poor prognosis in epithelial ovarian cancer patients: evidence from meta-analysis
- (2017) Bikang Yang et al. OncoTargets and Therapy
- CD117 expression is a predictive marker for poor prognosis in patients with non-small cell lung cancer
- (2017) Tomohiko Sakabe et al. Oncology Letters
- CD98 signals controlling tumorigenesis
- (2016) Hugh Ip et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells
- (2016) Maryam Abbaspour Babaei et al. Drug Design Development and Therapy
- CD117+ cells in the circulation are predictive of advanced prostate cancer
- (2015) Bethany A. Kerr et al. Oncotarget
- SCF, Regulated by HIF-1α, Promotes Pancreatic Ductal Adenocarcinoma Cell Progression
- (2015) Chuntao Gao et al. PLoS One
- Stem Cell Factor Is a Potent Endothelial Permeability Factor
- (2014) J. Y. Kim et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Antitumor Efficacy of a Bispecific Antibody That Targets HER2 and Activates T Cells
- (2014) T. T. Junttila et al. CANCER RESEARCH
- Ponatinib Induces Apoptosis in Imatinib-Resistant Human Mast Cells by Dephosphorylating Mutant D816V KIT and Silencing -Catenin Signaling
- (2014) B. Jin et al. MOLECULAR CANCER THERAPEUTICS
- Oncogenic Kit signals on endolysosomes and endoplasmic reticulum are essential for neoplastic mast cell proliferation
- (2014) Yuuki Obata et al. Nature Communications
- Imatinib sensitizes endometrial cancer cells to cisplatin by targeting CD117-positive growth-competent cells
- (2013) Xiuzhi Zhang et al. CANCER LETTERS
- Estimation of rat mammary tumor volume using caliper and ultrasonography measurements
- (2013) Ana Faustino-Rocha et al. LAB ANIMAL
- Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth
- (2013) Badreddin Edris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Preclinical safety profile of trastuzumab emtansine (T-DM1): Mechanism of action of its cytotoxic component retained with improved tolerability
- (2013) Kirsten Achilles Poon et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin–ATP-binding cassette G2 signaling
- (2012) W K Chau et al. ONCOGENE
- Stem Cell Factor Receptor/c-Kit: From Basic Science to Clinical Implications
- (2012) Johan Lennartsson et al. PHYSIOLOGICAL REVIEWS
- p53 Modulation as a Therapeutic Strategy in Gastrointestinal Stromal Tumors
- (2012) Joern Henze et al. PLoS One
- Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)
- (2011) H. M. Kantarjian et al. BLOOD
- Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome
- (2011) Lijing Luo et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- KIT as a Therapeutic Target in Metastatic Melanoma
- (2011) Richard D. Carvajal JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CD117 and Stro-1 Identify Osteosarcoma Tumor-Initiating Cells Associated with Metastasis and Drug Resistance
- (2010) Amit S. Adhikari et al. CANCER RESEARCH
- Elimination of Human Lung Cancer Stem Cells through Targeting of the Stem Cell Factor-c-kit Autocrine Signaling Loop
- (2009) V. Levina et al. CANCER RESEARCH
- Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors
- (2009) A. W. Gramza et al. CLINICAL CANCER RESEARCH
- The D816V Mutation of c-Kit Circumvents a Requirement for Src Family Kinases in c-Kit Signal Transduction
- (2009) Jianmin Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Higher susceptibility of NOG mice to xenotransplanted tumors
- (2009) Kazuhiko Machida et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Multitargeted tyrosine kinase inhibitor stimulates expression of IL-6 and activates JAK2/STAT5 signaling in acute myelogenous leukemia cells
- (2009) C Nishioka et al. LEUKEMIA
- The Aberrant Localization of Oncogenic Kit Tyrosine Kinase Receptor Mutants Is Reversed on Specific Inhibitory Treatment
- (2009) H. Bougherara et al. MOLECULAR CANCER RESEARCH
- Gab2 Is Involved in Differential Phosphoinositide 3-Kinase Signaling by Two Splice Forms of c-Kit
- (2008) Jianmin Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Heterogeneity of kinase inhibitor resistance mechanisms in GIST
- (2008) B Liegl et al. JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now